Brief: Tcr² Therapeutics Reports Third Quarter 2020 Financial Results And Provides Corporate Update
12/11/2020 11:50
Nov 12 (Reuters) - TCR2 Therapeutics Inc TCRR.O :
* TCR² THERAPEUTICS REPORTS THIRD QUARTER 2020 FINANCIAL
RESULTS
AND PROVIDES CORPORATE UPDATE
* TCR2 THERAPEUTICS INC QTRLY LOSS PER SHARE 56 CENTS
* TCR2 THERAPEUTICS INC - PROJECTS NET CASH USE OF $65-70
MILLION
FOR 2020
Source text for Eikon: ID:nGNX31RYDr
Further company coverage: TCRR.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on TCR2 Therapeutics
See all newsBrief: TCR2 Therapeutics Entered Into An Assignment Of Lease Agreement With Astrazeneca
TCR2 Therapeutics falls on bigger-than-expected Q1 loss
Brief: Tcr² Therapeutics Reports Q1 2023 Financial Results And Provides Corporate Update
TCR2 Therapeutics Inc reports results for the quarter ended in March - Earnings Summary
TCR2 Therapeutics Inc expected to post a loss of 68 cents a share - Earnings Preview